Other studies have reported that a high PIM-1 level correlates with good prognosis in prostate adenocarcinoma, pancreatic ductal carcinoma, and nonsmall cell lung cancer (Dhanasekaran et al., 2001; Reiser-Erkan et al., 2008; Warnecke-Eberz et al., 2008). Here, PIM1 is linked to prostate adenocarcinoma.